Federal Register / Vol. 87, No. 133 / Wednesday, July 13, 2022 / Notices 41721 

6 12 U.S.C. 1693o–2. 

7The subsection refers to bi-annual disclosures 

and the Board interprets this to mean once every 

two years. See 76 FR 43458. 

8 15 U.S.C. 1693o–2(a)(3)(B). 

9 Id. 

10 Id. 

11 5 U.S.C. 552(b)(4). 

amended by section 1075(a) of the 

Dodd-Frank Wall Street Reform and 

Consumer Protection Act.6 This 

provision requires the Board, at least 

once every two years,7 to disclose 

aggregate or summary information 

concerning the costs incurred and 

interchange transaction fees charged or 

received by issuers or payment card 

networks in connection with the 

authorization, clearance, or settlement 

of electronic debit transactions as the 

Board considers appropriate and in the 

public interest.8 It also provides the 

Board with authority to require issuers 

and payment card networks to provide 

information to enable the Board to carry 

out the provisions of the subsection.9

The FR 3064 surveys are mandatory. 

The Board is required to release 

aggregate information from responses to 

the FR 3064 surveys.10 The Board 

additionally releases, at the network 

level, the percentage of total number of 

transactions, the percentage of total 

value of transactions, and the average 

transaction value for exempt and nonexempt issuers obtained on the FR 

3064b because it can be calculated 

based on information the Board already 

releases and may be useful to issuers, 

merchants, and policymakers in 

choosing payment card networks and 

assessing the effects of interchange 

regulations. The information contained 

in individual responses to the FR 3064 

surveys is nonpublic commercial or 

financial information, which is both 

customarily and actually treated as 

private by the respondent. The Board 

therefore keeps such information 

confidential pursuant to exemption 4 of 

the Freedom of Information Act 

(FOIA).11

Board of Governors of the Federal Reserve 

System, July 7, 2022. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2022–14870 Filed 7–12–22; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[CDC–2019–0015, Docket Number NIOSH– 

153–E] 

Publication of Skin Notation Profile 

Documents for Chlorodiphenyl (54% 

Chlorine) (CAS: 11097–69–1), Diacetyl 

and 2,3-Pentanedione (CAS: 431–03–8; 

600–14–6), Dioxane (CAS: 123–91–1), 

Beta Chloroprene (CAS: 126–99–8), 

and 2,4-Toluene Diisocyanate, 2,6- 

Toluene Diisocyanate, and 2,4- and 2,6- 

Toluene Diisocyanate Mixture (CAS: 

584–84–9; 91–08–7; 26471–62–5 (as a 

Mixture)) 

AGENCY: The Centers for Disease Control 

and Prevention (CDC), Department of 

Health and Human Services (HHS). 

ACTION: Notice of availability. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) in the Centers for Disease 

Control and Prevention (CDC), an 

operating division of the Department of 

Health and Human Services (HHS), 

announces the availability of five 

documents, the Skin Notation Profiles 

for Chlorodiphenyl (54% chlorine) 

(CAS: 11097–69–1), Diacetyl and 2,3- 

Pentanedione (CAS: 431–03–8; 600–14– 

6), Dioxane (CAS: 123–91–1), beta 

Chloroprene (CAS: 126–99–8), and 2,4- 

Toluene diisocyanate, 2,6-Toluene 

diisocyanate, and 2,4- and 2,6-Toluene 

diisocyanate mixture (CAS: 584–84–9; 

91–08–7; 26471–62–5 (as a mixture)). 

DATES: The final documents were 

published on July 7, 2022 on the CDC 

website. 

ADDRESSES: The documents may be 

obtained at the following links: 

Chlorodiphenyl (54% chlorine) (CAS: 

11097–69–1): https://www.cdc.gov/ 

niosh/docs/2022-118/; 

Diacetyl and 2,3-Pentanedione (CAS: 

431–03–8; 600–14–6): https://

www.cdc.gov/niosh/docs/2022-116/; 

Dioxane (CAS: 123–91–1): https://

www.cdc.gov/niosh/docs/2022-114/; 

beta Chloroprene (CAS: 126–99–8): 

https://www.cdc.gov/niosh/docs/2022- 

115/; 

2,4-Toluene diisocyanate, 2,6-Toluene 

diisocyanate, and 2,4- and 2,6-Toluene 

diisocyanate mixture (CAS: 584–84–9; 

91–08–7; 26471–62–5 (as a mixture)): 

https://www.cdc.gov/niosh/docs/2022- 

117/. 

FOR FURTHER INFORMATION CONTACT: 

Naomi Hudson, NIOSH, 1090 Tusculum 

Ave., MS C–15, Cincinnati, OH 45226; 

Telephone 513–533–8388; Email: iuz8@

cdc.gov. 

SUPPLEMENTARY INFORMATION: On March 

15, 2019, NIOSH published a request for 

public comment in the Federal Register 

[Federal Register Number 2019–04794] 

[84 FR 9524] on the draft versions of the 

following skin notation profile 

documents: 

Beta-Chloroprene (CAS: 126–99–8) 

Cyclohexanol (CAS: 108–93–0) 

Cyclohexanone (CAS: 108–94–1) 

Cyclonite (CAS: 121–82–4) 

Dioxane (CAS: 123–91–1) 

Diacetyl/2,3-Pentanedione (CAS: 431– 

03–8; 600–14–6) 

Diethylenetriamine (CAS: 111–40–0) 

Chlorodiphenyl (42% chlorine) (CAS: 

53469–21–9) 

Chlorodiphenyl (54% chlorine) (CAS: 

11097–69–1) 

Toluene diisocyanates (CAS: 584–84–9; 

91–08–7; 26471–62–5) 

This notice announces that five of 

these documents have been finalized 

and published: Chlorodiphenyl (54% 

chlorine) (CAS: 11097–69–1), Diacetyl 

and 2,3-Pentanedione (CAS: 431–03–8; 

600–14–6), Dioxane (CAS: 123–91–1), 

beta Chloroprene (CAS: 126–99–8), and 

2,4-Toluene diisocyanate, 2,6-Toluene 

diisocyanate, and 2,4- and 2,6-Toluene 

diisocyanate mixture (CAS: 584–84–9; 

91–08–7; 26471–62–5 (as a mixture)). 

All comments received were carefully 

reviewed and addressed, where 

relevant. In response to comments 

received, revisions were made to clarify 

the data used by NIOSH in its support 

of the development of the skin notation 

assignments for these chemicals. NIOSH 

Skin Notation Profiles, Group E 

Responses to Peer Review and Public 

Comments can be found in the 

Supporting Documents section on 

www.regulations.gov for the CDC–2019– 

0015 docket. 

The other five documents were 

previously published in the Federal 

Register [Federal Register Number 

2020–25300] [85 FR 73481] on 

November 18, 2020 (https://

www.federalregister.gov/documents/ 

2020/11/18/2020-25300/skin-notationprofiles-for-chlorodiphenyl-42-chlorinecas-53469-21-9-cyclohexanol-cas-108- 

93-0): Chlorodiphenyl (42% chlorine) 

(CAS: 53469–21–9), Cyclohexanol (CAS: 

108–93–0), Cyclohexanone (CAS: 108– 

94–1), Cyclonite (CAS: 121–82–4), and 

Diethylenetriamine (CAS: 111–40–0). 

John J. Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2022–14906 Filed 7–12–22; 8:45 am] 

BILLING CODE 4163–18–P 


jspears on DSK121TN23PROD with NOTICES1